Moxie Dwight - Insider Non-Derivative Transactions at Revance Therapeutics, Inc. (RVNC) - (SEC)

Updated on January 3, 2026.

According to recent SEC insider information filed on Feb 6, 2025, Moxie Dwight's relationship to Revance Therapeutics, Inc. (RVNC) is Officer (CLO & GC), and currently has 18,125 shares of Common Stock.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other RVNC insiders.

Related Topics: SEC Topic List.

Data Source: SEC.

Moxie Dwight - Insider Non-Derivative Transactions of RVNC Common Stock

Moxie Dwight - Insider Non-Derivative Transactions at RVNC

Items per page:

0 of 0

Date	Transaction	No. of Shares	Price Per Share	Shares Owned After Transactions
Feb 7, 2025	Disposition -- (Common Stock)	18125	0	0
Feb 7, 2025	Disposition -- (Common Stock)	95979	0	0
Feb 7, 2025	Acquisition -- (Common Stock)	18125	0	18125
Feb 5, 2025	U -- (Common Stock)	47815	3.65	95979
Feb 4, 2025	Acquisition -- (Common Stock)	5979	0	143794
Mar 19, 2024	Sell -- (Common Stock)	8125	5.04	137815
Mar 16, 2024	F -- (Common Stock)	3269	5.31	145940
Mar 1, 2024	Acquisition -- (Common Stock)	15143	0	149209
Feb 1, 2024	Acquisition -- (Common Stock)	90000	0	134066
Sep 7, 2023	Sell -- (Common Stock)	11000	17.06	44066
Sep 6, 2023	Sell -- (Common Stock)	23853	17.81	55066
Aug 12, 2023	F -- (Common Stock)	9592	18.91	78919
Aug 12, 2023	Acquisition -- (Common Stock)	19346	0	88511
May 16, 2023	Sell -- (Common Stock)	21401	34.55	69165
Mar 16, 2023	F -- (Common Stock)	7330	30.65	48217
Mar 10, 2023	Sell -- (Common Stock)	18496	31.59	55547
Sep 23, 2022	Acquisition -- (Common Stock)	42349	0	74043
Feb 3, 2022	Acquisition -- (Common Stock)	42349	0	90566